CytoDyn Requests “Fast Track Approval” for COV
Post# of 148280
(Total Views: 638)
Posted On: 08/19/2020 1:25:45 AM
CytoDyn Requests “Fast Track Approval” for COVID-19 Patients from U.K.’s Regulatory Agency MHRA based on its Top-line Report Showing Statistically Significant Endpoint, NEWS2 (p < 0.023) and Notable Safety Results
https://www.cytodyn.com/investors/news-events...r-covid-19
https://www.cytodyn.com/investors/news-events...r-covid-19
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼